aluates Reports

$ 0.0

Automative

Global Juvenile Idiopathic Arthritis Therapeutics Market Research Report 2025

Published Date: January 2025

Report Code: QYRE-Auto-37S15196

Global Juvenile Idiopathic Arthritis Therapeutics Market Insights Forecast to 2029

BUY CHAPTERS

Global Juvenile Idiopathic Arthritis Therapeutics Market Research Report 2025

Code: QYRE-Auto-37S15196

Report

January 2025

Pages:76

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Johnson & Johnson Services Inc.

Novartis International AG

Bristol–Myers Squibb

Zydus Cadila

Takeda Pharmaceutical Company Limited

Genentech Inc

Latona Life Sciences

Juvenile Idiopathic Arthritis Therapeutics Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Juvenile Idiopathic Arthritis Therapeutics Market

The global market for Juvenile Idiopathic Arthritis Therapeutics was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

Juvenile Idiopathic Arthritis (JIA) therapeutics refers to the range of medical treatments and interventions used to manage and alleviate the symptoms of Juvenile Idiopathic Arthritis, a chronic autoimmune inflammatory condition that primarily affects children and adolescents. JIA is characterized by joint inflammation, pain, and swelling, and it can lead to long-term joint damage and disability if not effectively managed. The goal of JIA therapeutics is to control inflammation, relieve pain, improve joint function, and enhance the overall quality of life for young patients with the condition.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Juvenile Idiopathic Arthritis Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Juvenile Idiopathic Arthritis Therapeutics.

The Juvenile Idiopathic Arthritis Therapeutics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Juvenile Idiopathic Arthritis Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Juvenile Idiopathic Arthritis Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Juvenile Idiopathic Arthritis Therapeutics Market Report

Report Metric	Details
Report Name	Juvenile Idiopathic Arthritis Therapeutics Market
CAGR	5%
Segment by Type	Oral Subcutaneous
Segment by Application	Hospital Clinic Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Johnson & Johnson Services, Inc., Novartis International AG, Bristol-Myers Squibb, Zydus Cadila, Takeda Pharmaceutical Company Limited, Genentech, Inc., Latona Life Sciences.
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Juvenile Idiopathic Arthritis Therapeutics company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Juvenile Idiopathic Arthritis Therapeutics Market report?

Ans: The main players in the Juvenile Idiopathic Arthritis Therapeutics Market are Johnson & Johnson Services, Inc., Novartis International AG, Bristol-Myers Squibb, Zydus Cadila, Takeda Pharmaceutical Company Limited, Genentech, Inc., Latona Life Sciences.

What are the Application segmentation covered in the Juvenile Idiopathic Arthritis Therapeutics Market report?

Ans: The Applications covered in the Juvenile Idiopathic Arthritis Therapeutics Market report are Hospital, Clinic, Others

What are the Type segmentation covered in the Juvenile Idiopathic Arthritis Therapeutics Market report?

Ans: The Types covered in the Juvenile Idiopathic Arthritis Therapeutics Market report are Oral, Subcutaneous

Recommended Reports

Juvenile & Pediatric Diseases

Autoimmune & Arthritis

Rare & Inflammatory Diseases

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Juvenile Idiopathic Arthritis Therapeutics Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Oral

1.2.3 Subcutaneous

1.3 Market by Application

1.3.1 Global Juvenile Idiopathic Arthritis Therapeutics Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Hospital

1.3.3 Clinic

1.3.4 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Juvenile Idiopathic Arthritis Therapeutics Market Perspective (2020-2031)

2.2 Global Juvenile Idiopathic Arthritis Therapeutics Growth Trends by Region

2.2.1 Global Juvenile Idiopathic Arthritis Therapeutics Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Juvenile Idiopathic Arthritis Therapeutics Historic Market Size by Region (2020-2025)

2.2.3 Juvenile Idiopathic Arthritis Therapeutics Forecasted Market Size by Region (2026-2031)

2.3 Juvenile Idiopathic Arthritis Therapeutics Market Dynamics

2.3.1 Juvenile Idiopathic Arthritis Therapeutics Industry Trends

2.3.2 Juvenile Idiopathic Arthritis Therapeutics Market Drivers

2.3.3 Juvenile Idiopathic Arthritis Therapeutics Market Challenges

2.3.4 Juvenile Idiopathic Arthritis Therapeutics Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Juvenile Idiopathic Arthritis Therapeutics Players by Revenue

3.1.1 Global Top Juvenile Idiopathic Arthritis Therapeutics Players by Revenue (2020-2025)

3.1.2 Global Juvenile Idiopathic Arthritis Therapeutics Revenue Market Share by Players (2020-2025)

3.2 Global Juvenile Idiopathic Arthritis Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Juvenile Idiopathic Arthritis Therapeutics Revenue

3.4 Global Juvenile Idiopathic Arthritis Therapeutics Market Concentration Ratio

3.4.1 Global Juvenile Idiopathic Arthritis Therapeutics Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Juvenile Idiopathic Arthritis Therapeutics Revenue in 2024

3.5 Global Key Players of Juvenile Idiopathic Arthritis Therapeutics Head office and Area Served

3.6 Global Key Players of Juvenile Idiopathic Arthritis Therapeutics, Product and Application

3.7 Global Key Players of Juvenile Idiopathic Arthritis Therapeutics, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Juvenile Idiopathic Arthritis Therapeutics Breakdown Data by Type

4.1 Global Juvenile Idiopathic Arthritis Therapeutics Historic Market Size by Type (2020-2025)

4.2 Global Juvenile Idiopathic Arthritis Therapeutics Forecasted Market Size by Type (2026-2031)

5 Juvenile Idiopathic Arthritis Therapeutics Breakdown Data by Application

5.1 Global Juvenile Idiopathic Arthritis Therapeutics Historic Market Size by Application (2020-2025)

5.2 Global Juvenile Idiopathic Arthritis Therapeutics Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Juvenile Idiopathic Arthritis Therapeutics Market Size (2020-2031)

6.2 North America Juvenile Idiopathic Arthritis Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Juvenile Idiopathic Arthritis Therapeutics Market Size by Country (2020-2025)

6.4 North America Juvenile Idiopathic Arthritis Therapeutics Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Juvenile Idiopathic Arthritis Therapeutics Market Size (2020-2031)

7.2 Europe Juvenile Idiopathic Arthritis Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Juvenile Idiopathic Arthritis Therapeutics Market Size by Country (2020-2025)

7.4 Europe Juvenile Idiopathic Arthritis Therapeutics Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Juvenile Idiopathic Arthritis Therapeutics Market Size (2020-2031)

8.2 Asia-Pacific Juvenile Idiopathic Arthritis Therapeutics Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Juvenile Idiopathic Arthritis Therapeutics Market Size by Region (2020-2025)

8.4 Asia-Pacific Juvenile Idiopathic Arthritis Therapeutics Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Juvenile Idiopathic Arthritis Therapeutics Market Size (2020-2031)

9.2 Latin America Juvenile Idiopathic Arthritis Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Juvenile Idiopathic Arthritis Therapeutics Market Size by Country (2020-2025)

9.4 Latin America Juvenile Idiopathic Arthritis Therapeutics Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Juvenile Idiopathic Arthritis Therapeutics Market Size (2020-2031)

10.2 Middle East & Africa Juvenile Idiopathic Arthritis Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Juvenile Idiopathic Arthritis Therapeutics Market Size by Country (2020-2025)

10.4 Middle East & Africa Juvenile Idiopathic Arthritis Therapeutics Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Johnson & Johnson Services, Inc.

11.1.1 Johnson & Johnson Services, Inc. Company Details

11.1.2 Johnson & Johnson Services, Inc. Business Overview

11.1.3 Johnson & Johnson Services, Inc. Juvenile Idiopathic Arthritis Therapeutics Introduction

11.1.4 Johnson & Johnson Services, Inc. Revenue in Juvenile Idiopathic Arthritis Therapeutics Business (2020-2025)

11.1.5 Johnson & Johnson Services, Inc. Recent Development

11.2 Novartis International AG

11.2.1 Novartis International AG Company Details

11.2.2 Novartis International AG Business Overview

11.2.3 Novartis International AG Juvenile Idiopathic Arthritis Therapeutics Introduction

11.2.4 Novartis International AG Revenue in Juvenile Idiopathic Arthritis Therapeutics Business (2020-2025)

11.2.5 Novartis International AG Recent Development

11.3 Bristol-Myers Squibb

11.3.1 Bristol-Myers Squibb Company Details

11.3.2 Bristol-Myers Squibb Business Overview

11.3.3 Bristol-Myers Squibb Juvenile Idiopathic Arthritis Therapeutics Introduction

11.3.4 Bristol-Myers Squibb Revenue in Juvenile Idiopathic Arthritis Therapeutics Business (2020-2025)

11.3.5 Bristol-Myers Squibb Recent Development

11.4 Zydus Cadila

11.4.1 Zydus Cadila Company Details

11.4.2 Zydus Cadila Business Overview

11.4.3 Zydus Cadila Juvenile Idiopathic Arthritis Therapeutics Introduction

11.4.4 Zydus Cadila Revenue in Juvenile Idiopathic Arthritis Therapeutics Business (2020-2025)

11.4.5 Zydus Cadila Recent Development

11.5 Takeda Pharmaceutical Company Limited

11.5.1 Takeda Pharmaceutical Company Limited Company Details

11.5.2 Takeda Pharmaceutical Company Limited Business Overview

11.5.3 Takeda Pharmaceutical Company Limited Juvenile Idiopathic Arthritis Therapeutics Introduction

11.5.4 Takeda Pharmaceutical Company Limited Revenue in Juvenile Idiopathic Arthritis Therapeutics Business (2020-2025)

11.5.5 Takeda Pharmaceutical Company Limited Recent Development

11.6 Genentech, Inc.

11.6.1 Genentech, Inc. Company Details

11.6.2 Genentech, Inc. Business Overview

11.6.3 Genentech, Inc. Juvenile Idiopathic Arthritis Therapeutics Introduction

11.6.4 Genentech, Inc. Revenue in Juvenile Idiopathic Arthritis Therapeutics Business (2020-2025)

11.6.5 Genentech, Inc. Recent Development

11.7 Latona Life Sciences.

11.7.1 Latona Life Sciences. Company Details

11.7.2 Latona Life Sciences. Business Overview

11.7.3 Latona Life Sciences. Juvenile Idiopathic Arthritis Therapeutics Introduction

11.7.4 Latona Life Sciences. Revenue in Juvenile Idiopathic Arthritis Therapeutics Business (2020-2025)

11.7.5 Latona Life Sciences. Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Johnson & Johnson Services Inc.

Novartis International AG

Bristol–Myers Squibb

Zydus Cadila

Takeda Pharmaceutical Company Limited

Genentech Inc

Latona Life Sciences

List of Tables

Table 1. Global Juvenile Idiopathic Arthritis Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Oral

Table 3. Key Players of Subcutaneous

Table 4. Global Juvenile Idiopathic Arthritis Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 5. Global Juvenile Idiopathic Arthritis Therapeutics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Juvenile Idiopathic Arthritis Therapeutics Market Size by Region (2020-2025) & (US$ Million)

Table 7. Global Juvenile Idiopathic Arthritis Therapeutics Market Share by Region (2020-2025)

Table 8. Global Juvenile Idiopathic Arthritis Therapeutics Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 9. Global Juvenile Idiopathic Arthritis Therapeutics Market Share by Region (2026-2031)

Table 10. Juvenile Idiopathic Arthritis Therapeutics Market Trends

Table 11. Juvenile Idiopathic Arthritis Therapeutics Market Drivers

Table 12. Juvenile Idiopathic Arthritis Therapeutics Market Challenges

Table 13. Juvenile Idiopathic Arthritis Therapeutics Market Restraints

Table 14. Global Juvenile Idiopathic Arthritis Therapeutics Revenue by Players (2020-2025) & (US$ Million)

Table 15. Global Juvenile Idiopathic Arthritis Therapeutics Market Share by Players (2020-2025)

Table 16. Global Top Juvenile Idiopathic Arthritis Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Juvenile Idiopathic Arthritis Therapeutics as of 2024)

Table 17. Ranking of Global Top Juvenile Idiopathic Arthritis Therapeutics Companies by Revenue (US$ Million) in 2024

Table 18. Global 5 Largest Players Market Share by Juvenile Idiopathic Arthritis Therapeutics Revenue (CR5 and HHI) & (2020-2025)

Table 19. Global Key Players of Juvenile Idiopathic Arthritis Therapeutics, Headquarters and Area Served

Table 20. Global Key Players of Juvenile Idiopathic Arthritis Therapeutics, Product and Application

Table 21. Global Key Players of Juvenile Idiopathic Arthritis Therapeutics, Date of Enter into This Industry

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Juvenile Idiopathic Arthritis Therapeutics Market Size by Type (2020-2025) & (US$ Million)

Table 24. Global Juvenile Idiopathic Arthritis Therapeutics Revenue Market Share by Type (2020-2025)

Table 25. Global Juvenile Idiopathic Arthritis Therapeutics Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 26. Global Juvenile Idiopathic Arthritis Therapeutics Revenue Market Share by Type (2026-2031)

Table 27. Global Juvenile Idiopathic Arthritis Therapeutics Market Size by Application (2020-2025) & (US$ Million)

Table 28. Global Juvenile Idiopathic Arthritis Therapeutics Revenue Market Share by Application (2020-2025)

Table 29. Global Juvenile Idiopathic Arthritis Therapeutics Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 30. Global Juvenile Idiopathic Arthritis Therapeutics Revenue Market Share by Application (2026-2031)

Table 31. North America Juvenile Idiopathic Arthritis Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 32. North America Juvenile Idiopathic Arthritis Therapeutics Market Size by Country (2020-2025) & (US$ Million)

Table 33. North America Juvenile Idiopathic Arthritis Therapeutics Market Size by Country (2026-2031) & (US$ Million)

Table 34. Europe Juvenile Idiopathic Arthritis Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 35. Europe Juvenile Idiopathic Arthritis Therapeutics Market Size by Country (2020-2025) & (US$ Million)

Table 36. Europe Juvenile Idiopathic Arthritis Therapeutics Market Size by Country (2026-2031) & (US$ Million)

Table 37. Asia-Pacific Juvenile Idiopathic Arthritis Therapeutics Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 38. Asia-Pacific Juvenile Idiopathic Arthritis Therapeutics Market Size by Region (2020-2025) & (US$ Million)

Table 39. Asia-Pacific Juvenile Idiopathic Arthritis Therapeutics Market Size by Region (2026-2031) & (US$ Million)

Table 40. Latin America Juvenile Idiopathic Arthritis Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 41. Latin America Juvenile Idiopathic Arthritis Therapeutics Market Size by Country (2020-2025) & (US$ Million)

Table 42. Latin America Juvenile Idiopathic Arthritis Therapeutics Market Size by Country (2026-2031) & (US$ Million)

Table 43. Middle East & Africa Juvenile Idiopathic Arthritis Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 44. Middle East & Africa Juvenile Idiopathic Arthritis Therapeutics Market Size by Country (2020-2025) & (US$ Million)

Table 45. Middle East & Africa Juvenile Idiopathic Arthritis Therapeutics Market Size by Country (2026-2031) & (US$ Million)

Table 46. Johnson & Johnson Services, Inc. Company Details

Table 47. Johnson & Johnson Services, Inc. Business Overview

Table 48. Johnson & Johnson Services, Inc. Juvenile Idiopathic Arthritis Therapeutics Product

Table 49. Johnson & Johnson Services, Inc. Revenue in Juvenile Idiopathic Arthritis Therapeutics Business (2020-2025) & (US$ Million)

Table 50. Johnson & Johnson Services, Inc. Recent Development

Table 51. Novartis International AG Company Details

Table 52. Novartis International AG Business Overview

Table 53. Novartis International AG Juvenile Idiopathic Arthritis Therapeutics Product

Table 54. Novartis International AG Revenue in Juvenile Idiopathic Arthritis Therapeutics Business (2020-2025) & (US$ Million)

Table 55. Novartis International AG Recent Development

Table 56. Bristol-Myers Squibb Company Details

Table 57. Bristol-Myers Squibb Business Overview

Table 58. Bristol-Myers Squibb Juvenile Idiopathic Arthritis Therapeutics Product

Table 59. Bristol-Myers Squibb Revenue in Juvenile Idiopathic Arthritis Therapeutics Business (2020-2025) & (US$ Million)

Table 60. Bristol-Myers Squibb Recent Development

Table 61. Zydus Cadila Company Details

Table 62. Zydus Cadila Business Overview

Table 63. Zydus Cadila Juvenile Idiopathic Arthritis Therapeutics Product

Table 64. Zydus Cadila Revenue in Juvenile Idiopathic Arthritis Therapeutics Business (2020-2025) & (US$ Million)

Table 65. Zydus Cadila Recent Development

Table 66. Takeda Pharmaceutical Company Limited Company Details

Table 67. Takeda Pharmaceutical Company Limited Business Overview

Table 68. Takeda Pharmaceutical Company Limited Juvenile Idiopathic Arthritis Therapeutics Product

Table 69. Takeda Pharmaceutical Company Limited Revenue in Juvenile Idiopathic Arthritis Therapeutics Business (2020-2025) & (US$ Million)

Table 70. Takeda Pharmaceutical Company Limited Recent Development

Table 71. Genentech, Inc. Company Details

Table 72. Genentech, Inc. Business Overview

Table 73. Genentech, Inc. Juvenile Idiopathic Arthritis Therapeutics Product

Table 74. Genentech, Inc. Revenue in Juvenile Idiopathic Arthritis Therapeutics Business (2020-2025) & (US$ Million)

Table 75. Genentech, Inc. Recent Development

Table 76. Latona Life Sciences. Company Details

Table 77. Latona Life Sciences. Business Overview

Table 78. Latona Life Sciences. Juvenile Idiopathic Arthritis Therapeutics Product

Table 79. Latona Life Sciences. Revenue in Juvenile Idiopathic Arthritis Therapeutics Business (2020-2025) & (US$ Million)

Table 80. Latona Life Sciences. Recent Development

Table 81. Research Programs/Design for This Report

Table 82. Key Data Information from Secondary Sources

Table 83. Key Data Information from Primary Sources

Table 84. Authors List of This Report

List of Figures

Figure 1. Juvenile Idiopathic Arthritis Therapeutics Picture

Figure 2. Global Juvenile Idiopathic Arthritis Therapeutics Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Juvenile Idiopathic Arthritis Therapeutics Market Share by Type: 2024 VS 2031

Figure 4. Oral Features

Figure 5. Subcutaneous Features

Figure 6. Global Juvenile Idiopathic Arthritis Therapeutics Market Size by Application (2020-2031) & (US$ Million)

Figure 7. Global Juvenile Idiopathic Arthritis Therapeutics Market Share by Application: 2024 VS 2031

Figure 8. Hospital Case Studies

Figure 9. Clinic Case Studies

Figure 10. Others Case Studies

Figure 11. Juvenile Idiopathic Arthritis Therapeutics Report Years Considered

Figure 12. Global Juvenile Idiopathic Arthritis Therapeutics Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 13. Global Juvenile Idiopathic Arthritis Therapeutics Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 14. Global Juvenile Idiopathic Arthritis Therapeutics Market Share by Region: 2024 VS 2031

Figure 15. Global Juvenile Idiopathic Arthritis Therapeutics Market Share by Players in 2024

Figure 16. Global Top Juvenile Idiopathic Arthritis Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Juvenile Idiopathic Arthritis Therapeutics as of 2024)

Figure 17. The Top 10 and 5 Players Market Share by Juvenile Idiopathic Arthritis Therapeutics Revenue in 2024

Figure 18. North America Juvenile Idiopathic Arthritis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 19. North America Juvenile Idiopathic Arthritis Therapeutics Market Share by Country (2020-2031)

Figure 20. United States Juvenile Idiopathic Arthritis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 21. Canada Juvenile Idiopathic Arthritis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. Europe Juvenile Idiopathic Arthritis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Europe Juvenile Idiopathic Arthritis Therapeutics Market Share by Country (2020-2031)

Figure 24. Germany Juvenile Idiopathic Arthritis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. France Juvenile Idiopathic Arthritis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. U.K. Juvenile Idiopathic Arthritis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. Italy Juvenile Idiopathic Arthritis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Russia Juvenile Idiopathic Arthritis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Nordic Countries Juvenile Idiopathic Arthritis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Asia-Pacific Juvenile Idiopathic Arthritis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Asia-Pacific Juvenile Idiopathic Arthritis Therapeutics Market Share by Region (2020-2031)

Figure 32. China Juvenile Idiopathic Arthritis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Japan Juvenile Idiopathic Arthritis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. South Korea Juvenile Idiopathic Arthritis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Southeast Asia Juvenile Idiopathic Arthritis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. India Juvenile Idiopathic Arthritis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Australia Juvenile Idiopathic Arthritis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Latin America Juvenile Idiopathic Arthritis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Latin America Juvenile Idiopathic Arthritis Therapeutics Market Share by Country (2020-2031)

Figure 40. Mexico Juvenile Idiopathic Arthritis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Brazil Juvenile Idiopathic Arthritis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Middle East & Africa Juvenile Idiopathic Arthritis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Middle East & Africa Juvenile Idiopathic Arthritis Therapeutics Market Share by Country (2020-2031)

Figure 44. Turkey Juvenile Idiopathic Arthritis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Saudi Arabia Juvenile Idiopathic Arthritis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. UAE Juvenile Idiopathic Arthritis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Johnson & Johnson Services, Inc. Revenue Growth Rate in Juvenile Idiopathic Arthritis Therapeutics Business (2020-2025)

Figure 48. Novartis International AG Revenue Growth Rate in Juvenile Idiopathic Arthritis Therapeutics Business (2020-2025)

Figure 49. Bristol-Myers Squibb Revenue Growth Rate in Juvenile Idiopathic Arthritis Therapeutics Business (2020-2025)

Figure 50. Zydus Cadila Revenue Growth Rate in Juvenile Idiopathic Arthritis Therapeutics Business (2020-2025)

Figure 51. Takeda Pharmaceutical Company Limited Revenue Growth Rate in Juvenile Idiopathic Arthritis Therapeutics Business (2020-2025)

Figure 52. Genentech, Inc. Revenue Growth Rate in Juvenile Idiopathic Arthritis Therapeutics Business (2020-2025)

Figure 53. Latona Life Sciences. Revenue Growth Rate in Juvenile Idiopathic Arthritis Therapeutics Business (2020-2025)

Figure 54. Bottom-up and Top-down Approaches for This Report

Figure 55. Data Triangulation

Figure 56. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Rheumatoid Arthritis RA Medications Market Research Report 2025

Global Joint Disease Therapeutics Market Research Report 2024

Global Musculoskeletal Disorders Therapeutics Market Research Report 2025

Global Axial Spondyloarthritis Treatment Market Research Report 2024

Rheumatology Arthritis Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Amyloidosis Therapeutics Market Research Report 2024

Rheumatic Disorders Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Rheumatoid Arthritis Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Sacroiliitis Treatment Market Research Report 2024

Arthritis Pain Treatment Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Pediatric Asthma Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Juvenile Idiopathic Arthritis Treatment Market Insights Forecast to 2030

Global Juvenile Idiopathic Arthritis Diagnostic Market Research Report 2024

Global Juvenile Macular Degeneration Treatment Market Research Report 2024

Pediatric Respiratory Disease Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Psoriatic Arthritis Treatment Drugs Market Research Report 2025

Global Musculoskeletal System Disorder Therapeutics Market Research Report 2024

Global Tendonitis Treatment Drug Market Research Report 2025

Ankle Arthritis Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions